Clinical Trial Update: PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles [NA]

View source ↗

Summary

Clinical trial update for PicoWay 730 Resolve Fusion targeting benign pigmented lesions and facial wrinkles; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Pigmented Lesions
• Facial Wrinkles

Drugs mentioned

• PicoWay 730 Resolve Fusion

Snippet

Sponsor: Candela Corporation | Conditions: Benign Pigmented Lesions, Facial Wrinkles | NA | Status: COMPLETED | Results posted: 2023-12-01